
Hydrocortisone Base BP Micro
Hydrocortisone Base BP Micro is a highly purified, micronized form of hydrocortisone base compliant with British Pharmacopoeia (BP) standards. It is a white to off-white fine powder designed for enhanced solubility and bioavailability in pharmaceutical formulations. As a corticosteroid hormone analog, it exhibits potent anti-inflammatory, immunosuppressive, and anti-allergic activities. The micronized particle size (~93 microns) facilitates improved dispersion in topical, injectable, and oral dosage forms.
Hydrocortisone Base BP Micro
Primary UsesÂ
- Pharmaceutical Industry
- Used as an active ingredient in topical formulations such as creams, ointments, gels, and lotions for the treatment of inflammatory skin conditions including eczema, dermatitis, psoriasis, and allergic reactions.
- Incorporated in injectable and oral dosage forms for systemic corticosteroid therapy to manage autoimmune diseases, allergic reactions, adrenal insufficiency, and inflammatory disorders.
- Employed in ophthalmic preparations for eye inflammation and allergic conjunctivitis.
- Used in compounding pharmacies to prepare customized corticosteroid therapies.
- Veterinary Medicine
- Utilized in veterinary formulations for treating inflammatory and allergic conditions in animals.
Secondary Uses
- Cosmetic and Dermatological Research
- Used in anti-inflammatory cosmetic formulations under strict regulatory controls for sensitive skin treatments.
- Applied in research to study corticosteroid mechanisms of action and skin barrier modulation.
- Combination Drug Formulations
- Combined with antibiotics, antifungal agents, or local anesthetics to enhance therapeutic efficacy in multi-active topical treatments.
- Basic Identification Attributes
- Chemical Name (IUPAC): 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione
- Common/Trade Name: Hydrocortisone Base BP
- CAS Number: 50-23-7
- HS Code: 2937.29.00
- Molecular Formula: C21H30O5
- Synonyms: Cortisol; Hydrocortisone; 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione
- Physical & Chemical Properties
- Physical State: Micronized powder (particle size ~93 microns)
- Color & Odor: White to off-white; odorless or faint odor
- Melting Point: 213–216 °C (decomposes)
- Solubility: Practically insoluble in water; soluble in ethanol, acetone, and chloroform
- Stability: Stable under recommended storage; sensitive to light and moisture
- Safety & Hazard Attributes
- GHS Classification: Not classified as hazardous; may cause irritation on contact
- Toxicity: Low acute toxicity; systemic effects possible with long-term use
- Exposure Limits: No specific occupational limits; general good hygiene recommended
- Storage & Handling Attributes
- Container Type: Airtight, moisture-proof containers such as glass or HDPE
- Storage Conditions: Store in a cool, dry, dark environment away from light and moisture
- Shelf Life: Typically 24 months under proper storage conditions
- Handling Notes: Avoid dust inhalation; use adequate ventilation
- Regulatory & Compliance Attributes
- Compliant with British Pharmacopoeia (BP) standards
- Approved for pharmaceutical use by major regulatory agencies including FDA and EMA
- Usage controlled due to corticosteroid potency and side effect profiles
- Environmental & Health Impact
- Biodegradability: Moderate, steroid structure slows degradation
- Ecotoxicity: Potential endocrine disruptor; environmental release should be minimized
- Bioaccumulation: Not significant
- Carcinogenicity/Mutagenicity: Not classified
- Safety Handling Precautions
- PPE Required: Gloves, dust mask, protective eyewear when handling powder
- Handling Guidelines: Use in well-ventilated areas; avoid inhalation of dust and direct contact
- Hygiene Practices: Wash hands thoroughly after handling; avoid eating or smoking during use
- First Aid Measures
- Inhalation: Move affected person to fresh air; seek medical advice if symptoms persist
- Skin Contact: Wash thoroughly with soap and water; get medical attention if irritation occurs
- Eye Contact: Rinse eyes with plenty of water for 15 minutes; consult physician if irritation continues
- Ingestion: Rinse mouth; seek emergency medical care for significant ingestion
- Firefighting Measures
- Fire Hazards: Combustible powder; may emit toxic fumes such as carbon oxides on burning
- Extinguishing Media: Water spray, foam, dry chemical, or carbon dioxide (COâ‚‚)
- Special Precautions: Firefighters should wear protective clothing and self-contained breathing apparatus (SCBA)
- Decomposition Products: Carbon monoxide, carbon dioxide, and other toxic combustion products
Related products
Carbocisteine AJI 92
Dicyclomine Hydrochloride
Diloxanide Furoate
Ellagic Acid
Guaiphenesin BP
Iodine Crystals
Lidocaine HCL BP
Miconazole Nitrate BP
Miconazole Nitrate BP is a high-purity, pharmaceutical-grade antifungal agent conforming to British Pharmacopoeia (BP) specifications. It is widely used in the formulation of topical and oral pharmaceutical products for the treatment of fungal infections caused by dermatophytes and yeasts, including Candida species. Miconazole Nitrate functions by inhibiting the biosynthesis of ergosterol, a vital component of fungal cell membranes, leading to cell death.
This white to off-white crystalline powder is highly effective and exhibits broad-spectrum antifungal and some antibacterial activity. It is commonly utilized in creams, ointments, powders, and gel formulations.